Table 1:
Cutaneous lesions** | Mucosal lesions | |||
---|---|---|---|---|
HPV genera | EV | TMS | Recalcitrant warts-Non genital | Recalcitrant warts-Oral/Anogenital |
α | 2 | 2, 3, 7, 10, 26, 27, 28, 29, 57, 78, 91, 94, 117 | 6, 11, 13, 16#, 18#, 27, 30, 31#, 32, 33#, 35#, 39#, 40, 42, 43, 44, 45#, 51#, 52#, 53, 54, 56#, 58#, 59#, 61, 62, 66#, 67, 68#, 70, 71, 72, 73, 74, 81, 83, 84, 85, 86, 87, 89, 90 | |
β | 5, 8, 9, 12, 14, 15, 17, 19, 20, 21, 22, 23, 24, 25, 36, 37, 38, 47, 49, 50, 75, 76, 77, 80, 93, 96 | |||
γ | 4 | 4, 48, 60, 65, 88, 95, 126, 128, 129, 130, 131, 132, 133, 134, 142, 147, 148, 149, 154 | 153, 175, 180 | |
μ | 1, 61 | |||
ν | 41 |
Updated from Orth G., 2006, and Sterling J.C., 2916 (Orth, 2006; Sterling, 2016)
EV, epidermodysplasia verruciformis; HPV, human papilloma virus; TMS, the tree-man syndrome
High-risk oncogenic HPVs (https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer)